Skip to main content
. 2018 Aug 18;57(Suppl 5):v34–v39. doi: 10.1093/rheumatology/key081

Table 3.

Major and minor structural anomalies in infants of women in the LEF-treated and comparison groups

Anomaly LEF group Disease-matched comparison group Healthy comparison group
Major structural defects in live births, n (%) and diagnoses 3/56 (5.4) 4/95 (4.2)a 3/72 (4.2)b,c
Major structural defects in pregnancy losses, n (%) and diagnoses 0/7 3/11 (27.3) 0/3
Major structural defects in all pregnancies, n (%)d 3/63 (4.8) 7/106 (6.6) 3/75 (4.0)
Functional problems, diagnoses 1 hydronephrosis grade 2; 1 bilateral vesicoureteral reflux 1 unilateral hydronephrosis; 1 vesicoureteral reflux with unilateral duplicated collecting system 1 congenital esotropia; 1 neonatal encephalopathy and seizures secondary to subarachnoid bleed; 1 tracheomalacia
Minor structural anomalies, n (%)e
    0–1 12/51 (23.5) 39/90 (43.3) 33/65 (50.8)
    2 15/51 (29.4) 22/90 (24.4) 13/65 (20.0)
    ≥3 24/51 (47.1) 29/90 (32.2) 19/65 (29.2)
Pattern of minor anomalies 0 0 0

Adapted from Chambers et al. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheumatol 62:1494–503. Copyright © 2010 by John Wiley Sons, Inc. Adapted with permission from John Wiley & Sons, Inc. One twin of each liveborn twin pair was randomly selected for analysis; however, no twin was malformed.

a

Reported by mother.

b

Reported by mother; inguinal hernia in a full-term infant, requiring surgery.

c

Persistent and not due to trauma.

d

All pregnancies excluding loss to follow-up.

e

P= 0.05 for three-group overall comparison; P = 0.10 for three-group comparison of infants with three or more minor structural anomalies, by Chi-square test.